Responses
Clinical/translational cancer immunotherapy
Original research
Vδ2 T cells are associated with favorable clinical outcomes in patients with bladder cancer and their tumor reactivity can be boosted by BCG and zoledronate treatments
Compose a Response to This Article
Other responses
No responses have been published for this article.
